The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6 , Pages 1169-1177.e16 , December 2008

Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity

  • Eric P. Hanson, MD

      Affiliations

    • Division of Rheumatology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Linda Monaco-Shawver, BA

      Affiliations

    • Division of Allergy and Immunology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Laura A. Solt, BS

      Affiliations

    • Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pa
  • ,
  • Lisa A. Madge, PhD

      Affiliations

    • Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pa
  • ,
  • Pinaki P. Banerjee, PhD

      Affiliations

    • Division of Allergy and Immunology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Michael J. May, PhD

      Affiliations

    • Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pa
  • ,
  • Jordan S. Orange, MD, PhD

      Affiliations

    • Division of Allergy and Immunology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
    • Corresponding Author InformationReprint requests: Jordan S. Orange, MD, PhD, Children's Hospital of Philadelphia, Abramson Research Center 1016H, 3615 Civic Center Boulevard, Philadelphia, PA 19104.

Received 30 June 2008 ,Revised 18 August 2008 ,Accepted 20 August 2008.

  • Image Result

    Hypomorphic NEMO mutations. Each asterisk represents an individual patient, and mutation types are color-coded. Structural predictions indicate an extended α-helix structure with 2 coiled coils, a leu

    Hypomorphic NEMO mutations. Each asterisk represents an individual patient, and mutation types are color-coded. Structural predictions indicate an extended α-helix structure with 2 coiled coils, a leucine zipper, and zinc finger motifs. The minimal oligomerization domain, serine phosphorylation (p-S), ubiquitination (U), sumoylation (S), ubiquitin binding (NUB), and IKK binding/NEMO dimerization regions are shown. αH, Alpha helix; CC, coiled coil; LZ, leucine zipper; ZF, zinc finger.

  • Image Result
    NEMO phenotype maps. The following phenotypes are shown: ectodermal dysplasia (A), lymphedema/osteopetrosis (B), inflammatory disease (C), pyogenic infection (D), mycobacterial infection (E), TNF-α re

    NEMO phenotype maps. The following phenotypes are shown: ectodermal dysplasia (A), lymphedema/osteopetrosis (B), inflammatory disease (C), pyogenic infection (D), mycobacterial infection (E), TNF-α response (F), hyper-IgM phenotype/CD40 (G), IL-1/TLR response (H), TCR response (I), and mortality (J). Each oval represents the reported presence (shaded) or absence (dashed) of the indicated phenotype, and is intended to reflect the protein region affected.

  • Image Result
    Phenotype frequency of shared mutations. Each column represents a mutation that occurred in more than 1 individual. Frequency is depicted by quartile and is color-coded: high (red), intermediate (yell

    Phenotype frequency of shared mutations. Each column represents a mutation that occurred in more than 1 individual. Frequency is depicted by quartile and is color-coded: high (red), intermediate (yellow), and low (green) phenotype presence. IBD, Inflammatory bowel disease; SGA, small for gestational age; Spec. Ab, specific antibody.

  • Image Result
    Expression levels of reconstituted NEMO are equivalent by anti-NEMO Western blot, intracellular FACS, and GFP FACS. A, Cells from reconstituted lines were lysed and probed with anti-NEMO mAb specific

    Expression levels of reconstituted NEMO are equivalent by anti-NEMO Western blot, intracellular FACS, and GFP FACS. A, Cells from reconstituted lines were lysed and probed with anti-NEMO mAb specific for the NEMO leucine zipper. Actin blotting demonstrates equal loading. FACS to determine GFP expression was performed on NEMO reconstituted cells lines (B), which was evaluated by intracellular staining (n = 2) (C). The gray shaded area demonstrates fluorescence of isotype-control stained cells.

  • Image Result
    Decreased NF-κB reporter expression after stimulation with TNF-α and flagellin in reconstituted NEMO(-) cells and impaired IκB degradation in the L153R but not C417R cell line. A, Cells were stained w

    Decreased NF-κB reporter expression after stimulation with TNF-α and flagellin in reconstituted NEMO(-) cells and impaired IκB degradation in the L153R but not C417R cell line. A, Cells were stained with rat-Thy-1phycoerytherin and analyzed by FACS. Decreased levels of expression indicate decreased NF-κB activation in response to TNF-α and flagellin in L153R and C417R. Replicates of experiments indicate significant differences compared to rNEMO; means, SDs, and P values are shown in the box above the histogram. ΔMFI denotes the difference in mean fluorescence intensity between stimulated and unstimulated cells. B, Western blot of IκB levels from the various cell lines after TNF-α activation. Densitometry measurements of IκBα/actin normalized to time = 0 for each cell line are indicated below individual bands.

  • Image Result
    Apoptosis in TNF-α stimulated cells and A20 expression. A, Cell lines were activated with TNF-α, and apoptosis was measured by annexin-V and 7-AAD. B, Replicates (N = 3) and statistical evaluation of

    Apoptosis in TNF-α stimulated cells and A20 expression. A, Cell lines were activated with TNF-α, and apoptosis was measured by annexin-V and 7-AAD. B, Replicates (N = 3) and statistical evaluation of repeated apoptosis assays. C, A20 transcripts were quantified by using real-time PCR, and fold induction of A20 expression is reduced in L153R reconstituted NEMO(-) cells. The result is representative of 2 independently conducted experiments.

  • Image Result
    Electrophoregram of NEMO G1000T after sequencing of the gel-purified NEMO gene–specific long range PCR product, demonstrating hemizygous presence in the IKBKG gene-specific sequence of the male karyot

    Electrophoregram of NEMO G1000T after sequencing of the gel-purified NEMO gene–specific long range PCR product, demonstrating hemizygous presence in the IKBKG gene-specific sequence of the male karyotype Jurkat cell line, resulting in stop codon and predicted L334X protein.

  • Image Result
    Western blot of the parental Jurkat cell line (pNEMO) and NEMO-deficient line (NEMO[-]). Membranes were probed with rabbit polyclonal (left) and mouse monoclonal (right) antibodies, indicating the pre

    Western blot of the parental Jurkat cell line (pNEMO) and NEMO-deficient line (NEMO[-]). Membranes were probed with rabbit polyclonal (left) and mouse monoclonal (right) antibodies, indicating the presence of only a specific band at the expected molecular weight. P, polyclonal; M, monoclonal.

  • Image Result
    Model of innate immune signaling through NEMO. Signaling occurs through different groups of functionally related proteins downstream of TNFR and TLR5, which activate the IKK complex and lead to IκB de

    Model of innate immune signaling through NEMO. Signaling occurs through different groups of functionally related proteins downstream of TNFR and TLR5, which activate the IKK complex and lead to IκB degradation (1). IκB processing leads to nuclear NF-κB translocation (2) and gene transcription (3). Simultaneously, programmed cell death pathways are activated (4) and suppressed (5) by NF-κB–dependent (right orange line) and classical NF-κB–independent (left orange line) gene transcription, such as A20. Thus, a NEMO-dependent but NF-κB–independent pathway uncovered by NEMO-C417R may exist (6). IRAK, IL-1 receptor–associated kinase; TRAF, TNF receptor–associated family of proteins; TAB, TAK-binding protein; TAK, TGF-β activated kinase; MyD, myeloid differentiation; FADD, Fas-associated death domain-containing protein; TRADD, TNF receptor–associated death domain-containing protein; RIP, receptor-interacting protein; cyt. C, cytochrome C.

 Supported by National Institutes of Health (NIH) AI079731 (J.S.O.), US Immunodeficiency Network Grant NIH N01 AI-22070 (J.S.O., M.J.M.), NIH HL080612 (M.J.M), the Pennsylvania Department of Health (J.S.O.; the Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions from this study), a career development award from the American Academy of Allergy, Asthma & Immunology (J.S.O.), NIH 5T32CA009140-33 (E.P.H.), and the Penn Center for Clinical Immunology Jackson-Wade Fellowship (E.P.H.)

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01545-5

doi: 10.1016/j.jaci.2008.08.018

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6 , Pages 1169-1177.e16 , December 2008